Rhenman & Partners Asset Management AB
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1599882
Stockholm, V7
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$37,163,984
-$10,228,834 QoQ
Shares Held
48,100
-21.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
4.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rhenman & Partners Asset Management AB holds $297,378,771 across 37 Biotechnology names. REGN ranks #1 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
48,100 | $37,163,984 | |
| 2 | INSM |
INSMED Inc
|
159,760 | $26,123,955 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,485 | $19,417,791 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
75,890 | $14,347,004 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
24,050 | $12,589,453 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
207,000 | $11,693,430 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
34,465 | $11,403,434 | |
| 8 | RPRX |
Royalty Pharma plc
|
233,000 | $11,177,010 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,163,984 | 48,100 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $47,392,818 | 61,400 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,297,947 | 36,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,542,500 | 27,700 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,136,802 | 31,750 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $30,955,724 | 43,457 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $40,998,360 | 39,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $33,632,960 | 32,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,013,407 | 34,300 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $34,253,310 | 39,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $32,918,400 | 40,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $25,148,900 | 35,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $29,169,285 | 35,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $26,695,130 | 37,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $22,043,840 | 32,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,275,820 | 14,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $19,904,970 | 28,500 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $13,963,500 | 25,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,462,800 | 20,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $19,324,400 | 40,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $12,595,050 | 22,500 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $7,795,625 | 12,500 | Shares | Sole | 2020-07-16 | |
| No filing history on record for this holder in this stock. | ||||||